TerminatedNCT05629533

The Nanowear Wearable System SimpleSense Validation Trial for Cardiac Output, Cardiac Power Output and Pulmonary Artery Pressure.in Patients Undergoing Right Heart Catheterization

Sponsor: Nanowear Inc.

Trial Details

Condition	Right Heart Catheterization
Intervention	SimpleSense
Status	Terminated
Participants	13
Est. Completion	5 Mar 2025
Last Updated	9 Apr 2026

Primary Outcome

Cardiac output algorithm; Algorithm for Pulmonary Artery Pressure; Algorithm for Pulmonary Wedge Pressure

Eligibility Criteria

Inclusion Criteria

Inclusion Criteria: 1. Subject has provided informed consent 2. Male or female over the age of 18 years 3. The patient is undergoing right heart catheterization Exclusion Criteria: 1. Subject unwilling or unable to comply with wearing the Nanowear SimpleSense System. 2. Subjects who are pregnant 3. Severe aortic stenosis.

Trial Sites

Countries

United States

View Registry Entry

Related Analysis

Terminated Wearable Cardiac Monitoring Trial: Lessons from SimpleSense Validation Study for Right Heart Catheterisation

The SimpleSense wearable cardiac monitoring validation trial was terminated early with only 13 participants enrolled. This study aimed to validate algorithms for non-invasive cardiac output and pulmonary pressure estimation against right heart catheterisation.

Read full article →

This content is for educational purposes for healthcare professionals only and does not constitute clinical advice. Clinical decisions should be based on individual patient assessment, current guidelines, and appropriate specialist consultation. Editorial Standards · Privacy Policy · Terms of Service